Bahian, Chela N.

HRN: 16-39-20  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/30/2023
AMPICILLIN 1GM (VIAL)
12/30/2023
01/05/2024
IV
2 Grams
Q6
Thickly Msaf
Waiting Final Action 
12/30/2023
CO-AMOXICLAV 625MG (TAB)
12/30/2023
01/06/2024
PO
1 Tab
Bid
Thinly Msaf
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: